These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 16405606

  • 1. Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis.
    Kragballe K, van de Kerkhof PC.
    J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):39-44. PubMed ID: 16405606
    [Abstract] [Full Text] [Related]

  • 2. Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol.
    Cassano N, Miracapillo A, Coviello C, Loconsole F, Bellino M, Vena GA.
    Clin Drug Investig; 2006 Jan; 26(4):227-33. PubMed ID: 17163256
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM.
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [Abstract] [Full Text] [Related]

  • 4. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
    van de Kerkhof PC.
    Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial.
    Guenther L, Van de Kerkhof PC, Snellman E, Kragballe K, Chu AC, Tegner E, Garcia-Diez A, Springborg J.
    Br J Dermatol; 2002 Aug; 147(2):316-23. PubMed ID: 12174105
    [Abstract] [Full Text] [Related]

  • 6. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.
    McCormack PL.
    Drugs; 2011 Apr 16; 71(6):709-30. PubMed ID: 21504248
    [Abstract] [Full Text] [Related]

  • 7. Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment.
    Anstey AV, Kragballe K.
    Int J Dermatol; 2006 Aug 16; 45(8):970-5. PubMed ID: 16911387
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
    Xia L, Li R, Wang Y, Lin Z, Zheng J, Li X, Lu Q, Zhang J, Jin H, Fu L, Zhang X, Liu Y, Yang S, Xiao F, Gao XH.
    Dermatol Ther; 2018 Sep 16; 31(5):e12632. PubMed ID: 30253049
    [Abstract] [Full Text] [Related]

  • 11. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
    Fleming C, Ganslandt C, Guenther L, Johannesson A, Buckley C, Simon JC, Stegmann H, Vestergaard Tingleff L.
    Eur J Dermatol; 2010 Sep 16; 20(4):465-71. PubMed ID: 20413372
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K, Hoffmann V, Ortonne JP, Tan J, Nordin P, Segaert S.
    Br J Dermatol; 2009 Jul 16; 161(1):159-66. PubMed ID: 19416259
    [Abstract] [Full Text] [Related]

  • 13. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.
    Douglas WS, Poulin Y, Decroix J, Ortonne JP, Mrowietz U, Gulliver W, Krogstad AL, Larsen FG, Iglesias L, Buckley C, Bibby AJ.
    Acta Derm Venereol; 2002 Jul 16; 82(2):131-5. PubMed ID: 12125943
    [Abstract] [Full Text] [Related]

  • 14. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris.
    Fenton C, Plosker GL.
    Am J Clin Dermatol; 2004 Jul 16; 5(6):463-78. PubMed ID: 15663344
    [Abstract] [Full Text] [Related]

  • 15. Low incidence of hypercalcemia following combined calcipotriol hydrate/betamethasone dipropionate ointment treatment in Japanese patients with severe psoriasis vulgaris.
    Morita A, Muramatsu S, Kubo R, Ikumi K, Sagawa Y, Saito C, Torii K, Nishida E.
    J Dermatolog Treat; 2018 Aug 16; 29(5):496-500. PubMed ID: 29076379
    [Abstract] [Full Text] [Related]

  • 16. A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris.
    Kaufmann R, Bibby AJ, Bissonnette R, Cambazard F, Chu AC, Decroix J, Douglas WS, Lowson D, Mascaro JM, Murphy GM, Stymne B.
    Dermatology; 2002 Aug 16; 205(4):389-93. PubMed ID: 12444337
    [Abstract] [Full Text] [Related]

  • 17. Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid.
    Tosti A, Piraccini BM, Cameli N, Kokely F, Plozzer C, Cannata GE, Benelli C.
    Br J Dermatol; 1998 Oct 16; 139(4):655-9. PubMed ID: 9892909
    [Abstract] [Full Text] [Related]

  • 18. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C, Hoffmann V, Shapiro J, Saari S, Cambazard F, Milsgaard M.
    Dermatology; 2008 Oct 16; 217(2):107-13. PubMed ID: 18463448
    [Abstract] [Full Text] [Related]

  • 19. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC, Hoffmann V, Anstey A, Barnes L, Bolduc C, Reich K, Saari S, Segaert S, Vaillant L.
    Br J Dermatol; 2009 Jan 16; 160(1):170-6. PubMed ID: 19067709
    [Abstract] [Full Text] [Related]

  • 20. A two-compound product containing calcipotriol and betamethasone dipropionate provides rapid, effective treatment of psoriasis vulgaris regardless of baseline disease severity.
    van de Kerkhof PC, Wasel N, Kragballe K, Cambazard F, Murray S.
    Dermatology; 2005 Jan 16; 210(4):294-9. PubMed ID: 15942215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.